GlassScriptPhysician profile
Ross J Girvan
NPI 1164449864
$10,921.86
in general payments reported to CMS, 2019-2025
35 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,724 · 2020: $2,352 · 2021: $1,008 · 2022: $1,882 · 2023: $394 · 2024: $833 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,955.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,835.70 | 2019-2025 | Prostep, Infinity Adaptis, Easyfuse |
| Medical Device Business Services, INC. | $2,566.73 | 2019 | |
| Wright Medical Technology, INC. | $1,176.63 | 2019-2020 | |
| Linvatec Corporation | $832.31 | 2020-2025 | Biobrace 23mm, Allograft Tissue |
| Depuy Synthes Sales INC. | $673.72 | 2019 | |
| Organogenesis INC. | $503.03 | 2020-2025 | Apligraf, Affinity, Puraply |
| Melinta Therapeutics, LLC | $324.86 | 2019-2024 | Kimyrsa, Orbactiv |
| Paratek Pharmaceuticals, INC. | $310.61 | 2020-2024 | Nuzyra |
| Horizon Therapeutics Plc | $242.33 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $236.33 | 2021-2025 | Grafix, Stravix, Regranex |
| Convatec INC. | $136.01 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $130.96 | 2019-2025 | Exparel |
| Bioventus LLC | $108.06 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $107.11 | 2024-2025 | Qutenza |
| Checkpoint Surgical, INC | $93.09 | 2021-2024 | Checkpoint Stimulators |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $77.70 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $53.95 | 2019 | |
| Fortis Surgical, LLC | $48.98 | 2021-2025 | |
| Kci USA, INC. | $47.26 | 2019-2023 | Activ.A.C., V.A.C. Dermatac, Promogran |
| Trice Medical, INC. | $45.66 | 2021 | |
| Triad Life Sciences INC. | $41.08 | 2022 | |
| Sebela Pharmaceuticals INC. | $38.40 | 2022-2023 | Naftin, Pramosone |
| Nabriva Therapeutics, Plc | $35.77 | 2021-2022 | |
| Abbott Laboratories | $34.51 | 2021-2023 | Proclaim |
| Medtronic, INC. | $28.53 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Heron Therapeutics, INC. | $27.80 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $26.47 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $26.44 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $25.68 | 2025 | Purified Cortrophin Gel |
| Grt US Holding, INC. | $18.84 | 2022 | |
| Access Pro Medical, LLC | $16.08 | 2022 | |
| Aroa Biosurgery Incorporated | $14.57 | 2019 | |
| Dynasplint Systems INC. | $13.73 | 2023 | Dynasplint |
| Arteriocyte Medical Systems, INC. | $13.00 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $9.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Girvan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.